Thrombosis in stem cell transplantation

Hematology

Volumn 17, Issue SUPPL. 1, 2012, Pages

  Kansu, Emin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Sinusoidal obstructive syndrome; Stem cell transplantation; Thrombosis; Transplant associated thrombotic microangiopathy

Indexed keywords

ACETYLCYSTEINE; ALTEPLASE; BUSULFAN; CORTICOSTEROID DERIVATIVE; COUMARIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEFIBROTIDE; DIURETIC AGENT; ECULIZUMAB; GEMTUZUMAB OZOGAMICIN; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; MYELOTARG; PLACEBO; RAPAMYCIN; RITUXIMAB; THROMBIN INHIBITOR; UNCLASSIFIED DRUG; WARFARIN;

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; ASCITES; AUTOLOGOUS STEM CELL TRANSPLANTATION; CATHETER THROMBOSIS; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG MEGADOSE; EARLY INTERVENTION; FLUID BALANCE; HUMAN; INCIDENCE; LOW DRUG DOSE; LUNG EMBOLISM; MORBIDITY; MORTALITY; PARACENTESIS; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SHUNTING; SODIUM BALANCE; STEM CELL TRANSPLANTATION; SURVIVAL RATE; SYMPTOMATOLOGY; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSHEPATIC SHUNT; TREATMENT INDICATION; TREATMENT RESPONSE; VEIN OCCLUSION; VENOUS THROMBOEMBOLISM; WHOLE BODY RADIATION;

CATHETERS; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; STEM CELL TRANSPLANTATION; THROMBOSIS; THROMBOTIC MICROANGIOPATHIES; VENOUS THROMBOEMBOLISM;

EID: 84859750987     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453312X13336169156735     Document Type: Article

References (18)

1. Nadir Y, Brenner B. Hemorrhagic and thrombotic complications in bone marrow transplant recipients. Thromb Res. 2007;120 Suppl 2:S92-8.
2. Pihusch M. Bleeding complications after hematopoietic stem cell transplantation. Semin Hematol. 2004;41(1 Suppl 1):93-100.
3. Graf L, Stern M. Acute phase after hematopoietic stem cell transplantation. Bleeding and thrombotic complications. Hamostaseologie. 2012;32:1-7.
4. Pihusch R, Salat C, Schmidt E, Gobring P, Pihusch M, Hiller E, et al. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation. 2002;74:1303-9.
5. Miano M, Faraci M, Dini G, Mardigoni P, on behalf of the EBMT Paediatric Working Party. Early complications following haematopoietic SCT in children. Bone Marrow Transplant. 2008;41:S39-42.
6. Paz IB. Vascular access and complications. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, editors. Thomas's hematopoietic cell transplantation, ed. Oxford: Wiley-Blackwell; 2008. p. 1244-56.
7. Gonsalves A, Carrier M, Wells PS, McDiarmid SA, Huebsch LB, Allan DS. Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation. J Thromb Haemost. 2008;6:1468-73.
8. Strasser SI, McDonald GB. Gastrointestinal and hepatic complications. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, editors. Thomas's hematopoietic cell transplantation, ed. Oxford: Wiley-Blackwell; 2008. p. 1434-55.
9. Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant. 2010;16:157-68.
10. Vassal G, Koscielny S, Challine D, Valteau-Couanet D, Boland I, Deroussent A, et al. Busulfan disposition and hepatic venoocclusive disease in children undergoing bone marrow transplantation. Cancer Chemother Pharmacol. 1996;37:247-53.
11. Hasegawa S, Horibe K, Kawabe T, Kato K, Kojima S, Matsuyama T, et al. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors. Bone Marrow Transplant. 1998;22:1191-7.
12. Pihusch V, Pihusch M, Penovici M, Kolb HJ, Hiller E, Pihusch R. Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoietic stem cell transplantation. Thromb Res. 2005;116:233-40.
13. Ho VT, Revta C, Richardson PG. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Bone Marrow Transplant. 2008;41:229-37.
14. Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J, et al. Defibrotide for the treatment of severe hepatic venoocclusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. Biol Blood Marrow Transplant. 2010;16:1005-17.
15. Sullivan KM, Kansu E, Storer B, Jocom J, Emerson G, Reagan T, et al. Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation. Biol Blood Marrow Transplant. 1998;41:20-6.
16. Batts ED, Lazarus HM. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? Bone Marrow Transplant. 2007;40:709-19.
17. Laskin BL, Goebel J, Davies SM, Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood. 2011;118:1452-62.
18. Cho BS, Yahng SA, Lee SE, Eom KS, Kim YJ, Kim HJ, et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation. 2010;90:918-26.